Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
IRCCS San Raffaele |
---|---|
Information provided by: | IRCCS San Raffaele |
ClinicalTrials.gov Identifier: | NCT00420901 |
chronic PDE5-Inhibition improves endothelial function in diabetics
Condition | Intervention | Phase |
---|---|---|
Diabetes |
Drug: sildenafil |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Effect of Chronic Administration of Sildenafil on Endothelial Function in Men With Diabetes |
Estimated Enrollment: | 30 |
Study Start Date: | January 1999 |
Estimated Study Completion Date: | February 2000 |
Evaluation of endothelial function at baseline and after chronic administration of sildenafil in male subjects with diabetes
Ages Eligible for Study: | 35 Years to 75 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | HSRRM1999/4 |
Study First Received: | January 9, 2007 |
Last Updated: | January 9, 2007 |
ClinicalTrials.gov Identifier: | NCT00420901 |
Health Authority: | Italy: Ethics Committee |
function inhibition |
Metabolic Diseases Diabetes Mellitus Endocrine System Diseases Sildenafil |
Endocrinopathy Metabolic disorder Glucose Metabolism Disorders |
Vasodilator Agents Phosphodiesterase Inhibitors Molecular Mechanisms of Pharmacological Action Therapeutic Uses |
Enzyme Inhibitors Cardiovascular Agents Pharmacologic Actions |